Status:
ACTIVE_NOT_RECRUITING
Feasibility of Molecular Biology in Pancreatic Cyst Tumors
Lead Sponsor:
Hospital St. Joseph, Marseille, France
Collaborating Sponsors:
Ramsay Générale de Santé
Conditions:
Pancreatic Cyst
Pancreas Cyst
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The main objective of the study is to compare the diagnostic accuracy of intra-cystic fluid DNA molecular analysis to standard diagnostics. The secondary objective of the study is to evaluate the fea...
Detailed Description
Multicenter study to determinate the feasibility of intra-cystic fluid DNA molecular analysis in patients with suspected cystic tumours of pancreas in whom EUS FNA is clinically indicated. Morphologi...
Eligibility Criteria
Inclusion
- Patient older than 18 years of age, male or female
- Cystic tumor of the pancreas requiring a puncture under endoscopic control to determine the etiologic diagnosis and gravity.
Exclusion
- Doubts regarding the etiological diagnosis of the pancreatic cyst
- Contraindications for the realization of a high digestive endoscopy
- Haemorrhagic disorder, haemostasis and coagulation disorder (TP \<60%, TCa\> 40 sec and platelets \<60000 / mm3).
- AVK, AOD and AAP cannot be stopped
Key Trial Info
Start Date :
January 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2027
Estimated Enrollment :
93 Patients enrolled
Trial Details
Trial ID
NCT03305146
Start Date
January 1 2017
End Date
January 1 2027
Last Update
April 14 2022
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinique de Bercy
Charenton-le-Pont, France, 94220
2
Centre Hospitalier Universitaire Dupuytren
Limoges, France, 87000
3
Hopital Edouard Herriot
Lyon, France, 69003
4
Hopital Mermoz
Lyon, France, 69008